tldrdailynews.com logo

FDA Approves Moderna's New COVID-19 Vaccine with Restrictions

1 min read
Source: CIDRAP
FDA Approves Moderna's New COVID-19 Vaccine with Restrictions
Photo: CIDRAP
TL;DR

The FDA has approved Moderna's new COVID-19 vaccine, mNexspike, which is a lower-dose, potentially refrigerator-stable shot targeting the spike protein, for use in adults 65 and older and high-risk individuals aged 12-64, based on successful phase 3 trial results. The vaccine is expected to be available for the 2025-26 season alongside Spikevax.

Topics:businesshealth#covid-19-vaccine#fda-approval#health#mnexspike#moderna#vaccination
Share this article
  1. FDA approves Moderna's new COVID-19 vaccine  CIDRAP
  2. The FDA Just Approved a New Covid Vaccine  Mother Jones
  3. FDA grants limited approval to new Covid vaccine from Moderna  NBC News
  4. Another Covid vaccine approval with restrictions attached  statnews.com
  5. How Moderna Went From Pandemic Hero to Vaccine Victim  WSJ

Want the full story? Read the original reporting

Read on CIDRAP